Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

Related Articles by Review for PubMed (Select 15152060)

1.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

N Engl J Med. 2004 May 20;350(21):2151-8.

3.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
4.

Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.

Grimm W, Maisch B.

Herz. 2002 Dec;27(8):750-9. Review.

PMID:
12574892
5.

[Idiopathic dilated cardiomyopathy--an appraisal in 2005].

Antz M, Bänsch D.

Herz. 2005 Mar;30(2):87-90. Review. German.

PMID:
15875096
6.

[Risk stratification for sudden cardiac death in post-infarct patients and in patients with dilated cardiomyopathy].

Grimm W.

Z Kardiol. 2000;89 Suppl 10:11-9; discussion 19-20. Review. German.

PMID:
11151769
8.

Nonsustained ventricular tachycardia in dilated cardiomyopathy.

Cuoco FA, Singh SN.

Curr Cardiol Rep. 2005 Sep;7(5):368-75. Review.

PMID:
16105493
9.

Primary prevention of sudden cardiac death: indications for cardioverter-defibrillator implantation.

Botto GL, Proclemer A, Luzi M, Ruffa F, Gorgoglione MG, Ferrari G.

Ital Heart J. 2005 Mar;6(3):210-5. Review.

PMID:
15875511
10.
11.

Management of hypertrophic cardiomyopathy in children.

Seggewiss H, Rigopoulos A.

Paediatr Drugs. 2003;5(10):663-72. Review.

PMID:
14510624
12.

Can antiarrhythmic drugs survive survival trials?

Pratt CM, Waldo AL, Camm AJ.

Am J Cardiol. 1998 Mar 19;81(6A):24D-34D. Review.

PMID:
9537220
13.

A comprehensive approach to management of ventricular arrhythmias.

Kusumoto F.

Cardiol Clin. 2008 Aug;26(3):481-96, vii. doi: 10.1016/j.ccl.2008.03.002. Review.

PMID:
18538192
14.

Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.

Klein MH, Gold MR.

Cardiol Clin. 2008 Aug;26(3):419-31, vi-vii. doi: 10.1016/j.ccl.2008.03.006. Review.

PMID:
18538188
15.

[The stratification and prevention of the arrhythmia risk in nonischemic dilated cardiomyopathy].

Ansalone G, Giannantoni P, Santini M.

G Ital Cardiol. 1998 Nov;28(11):1288-302. Review. Italian.

PMID:
9866807
16.

[Heart failure].

Yonezawa M, Komuro I.

Nihon Rinsho. 2002 Jul;60(7):1422-6. Review. Japanese.

PMID:
12136624
17.

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.

Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A.

Heart Rhythm. 2010 Jul;7(7):876-82. doi: 10.1016/j.hrthm.2010.03.042. Epub 2010 Apr 7. Review.

PMID:
20380893
18.

Sudden cardiac death and implantable cardioverter-defibrillators.

Turakhia MP.

Am Fam Physician. 2010 Dec 1;82(11):1357-66. Review.

20.

The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.

Disertori M, Quintarelli S, Mazzola S, Favalli V, Narula N, Arbustini E.

Europace. 2013 Dec;15(12):1693-701. doi: 10.1093/europace/eut228. Epub 2013 Aug 14. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk